Ke Chen
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 1%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 19
- Circular RNAs in diseases 16
- Epigenetics and DNA Methylation 13
- RNA Research and Splicing 12
- Ubiquitin and proteasome pathways 9
-
- Cancer-related molecular mechanisms research 30
- MicroRNA in disease regulation 15
- Co-authors
- Joel Anne Chasis (2 shared papers)Narla Mohandas (2 shared papers)Xiuli An (2 shared papers)Hua Xu (17 shared papers)Zhangqun Ye (16 shared papers)Susanne Heck (1 shared paper)Jing Liu (1 shared paper)Chunjiang He (6 shared papers)
- Journals
- Oncotarget (8 papers)Nucleic Acids Research (4 papers)Journal of Natural Products (4 papers)Journal of Cardiovascular Electrophysiology (3 papers)Hypertension (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ke Chen
207 papers receiving 6.8k citations
Ke Chen's Hit Papers
Peers
Comparison fields: 5 of 161
- Cancer Research 1.8k
- Molecular Biology 3.7k
- Geriatrics and Gerontology 166
- Immunology 553
- Epidemiology 760
Countries citing papers authored by Ke Chen
This map shows the geographic impact of Ke Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Chen more than expected).
Fields of papers citing papers by Ke Chen
This network shows the impact of papers produced by Ke Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Chen. The network helps show where Ke Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 216 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 390 | |
| 2 | 2017 | 317 | |
| 3 | 2006 | 303 | |
| 4 | CircRNA inhibits DNA damage repair by interacting with host gene Hit paper breakdown → | 2020 | 294 |
| 5 | 2015 | 178 | |
| 6 | 2014 | 167 | |
| 7 | 1997 | 145 | |
| 8 | 2013 | 137 | |
| 9 | 2015 | 128 | |
| 10 | 2013 | 127 | |
| 11 | 2014 | 124 | |
| 12 | 2008 | 112 | |
| 13 | 2018 | 112 | |
| 14 | 2013 | 102 | |
| 15 | 2013 | 102 | |
| 16 | 2011 | 102 | |
| 17 | 2014 | 95 | |
| 18 | 2020 | 94 | |
| 19 | 2003 | 89 | |
| 20 | 2014 | 85 |
About Ke Chen
Ke Chen is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 216 papers that have together received 6.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (30 papers), RNA modifications and cancer (19 papers), Circular RNAs in diseases (16 papers), MicroRNA in disease regulation (15 papers), Epigenetics and DNA Methylation (13 papers), RNA Research and Splicing (12 papers), Autophagy in Disease and Therapy (11 papers) and Ubiquitin and proteasome pathways (9 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (3.7k citations), Geriatrics and Gerontology (166 citations), Immunology (553 citations) and Epidemiology (760 citations). Ke Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Joel Anne Chasis, Narla Mohandas, Xiuli An, Hua Xu, Zhangqun Ye, Susanne Heck, Jing Liu, Chunjiang He, Haibing Xiao and Hongliang Li. Their work appears in journals such as Oncotarget, Nucleic Acids Research, Journal of Natural Products, Journal of Cardiovascular Electrophysiology and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.